Trial NCT01990352

View at ClinicalTrials.gov 
Org. Study IDs: 1300000710

Last trial update was posted on 2023-11-21

MeSH Interventions

Doxorubicin Liposomal doxorubicin

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

The PI determined that study specimens being obtained did not yield sufficient data to analyze the prespecified outcome measures and decided to terminate the study prior to meeting enrollment goals.

Limitations And Caveats

The trial was started with preliminary data on BRCA1 immunohistochemistry assay developed with a collaborator. The assay, in the trial, due to differences in the timeline on when the tumor tissue was collected, the variability in the tumor tissue processing, storage, and age of the samples, the assay did not work on the samples as projected. Subsequently, due to COVID-19 and the challenges with the assay performance, the collaborator discontinued further development of the assay.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID